Affiner votre recherche
Résultats 1-2 de 2
Evaluation of Type 1 and 3 Collagen Genes Expression in the Distal Limb Wounds Treated with Adipose-Derived Mesenchymal Stem Cells and its Comparison with Bone Marrow-Derived Stem Cells in Horses
2021
Malekshahinejad, Mohammad Mehdi | Ghamsari, Seyed Mehdi | Dehghan, Mohammad Mehdi | Nikbakhat-Brojeni, Gholamreza | Izadi, Seyed Sadra
BACKGROUND: Open wounds affecting the distal part of limbs are commonly seen in horses. Due to certain factors, such as limited connective tissue available, potentiated growth of excessive granulation tissue, risk of contamination, and poor response to common treatments, healing of these wounds becomes a major problem for veterinarians on a number of occasions. Application of Mesenchymal Stem Cells (MSC) for enhancing wound healing has received a great deal of scientific attention. Among the MSCs, those derived from adipose tissue are frequently used owing to their availability, large number of cells after the primary harvest, and the capacity to differentiate to different cell lines.OBJECTIVES: The current study aimed to evaluate type 1 and 3 collagen genes expression in horse distal limb wounds treated via adipose-derived Mesenchymal Stem Cells and its comparison with bone marrow-derived stem cells.METHODS: After treatment of the experimental open wounds created in the distal limbs of four horses via autologous MSCs, real-time PCR was used for evaluating and comparing the expression of type I and III collagen genes in the healing wounds.RESULTS: Significant differences in the expression of type I and III collagen genes were observed between the treatment groups. Despite the fact that the greatest collagen genes expression belonged to bone marrow-derived MSCs, no significant differences were seen with adipose-derived MSCs.CONCLUSIONS: Owing to the advantages and an acceptable performance, adipose-derived MSCs could be considered as a novel approach to enhancing limb wound healing in horses.
Afficher plus [+] Moins [-]Effect of Flufenamic Acid as Connexin Inhibitor on Diabetic Wound Healing
2020
Fotowat, Aysan | Ahmadpanahi, Seyed Javad | Shahroozian, Ebrahim | Hayati, Farzad | Ghaffari Khaligh, Sahar
BACKGROUND: Flufenamic acid is a member of the fenamates and is used as an analgesic and NSAID drug. According to the ability of this drug on blocking connexin and preventing leakage of substances such as ATP from cells, it seems to be beneficial in healing diabetic wounds. OBJECTIVES: Evaluation of the effects of topical flufenamic acid as a connexin-channel blocker on skin wound healing in alloxan-induced diabetic rats. METHODS: In this study diabetics was induced in 40 male rats by IP injection of 150mg/kg of alloxan and they were divided to 4 groups. After anesthesia, 2×2 cm incision was made on the back of the rats and the skin was separated completely. Three groups were treated by 2, 5 and 10 percent concentration of flufenamic acid ointment separately, and one group was treated by Vaseline and ucerine ointment as control. Bandage and ointment were changed daily and the procedure was carried out for 21 days. The wound surface was measured on odd days. Half of the rats of each group on day five and half of them on day 21 were euthanized to get pathologic slides. RESULTS: Process of healing, fibroblast concentration, epithelialization, angiogenesis, collagen formation and wound closure in 2 percent group were better than other groups and in control, 5 and 10 percent groups had a decreasing trend respectively and had a significant difference. In the last two groups, the healing process was disrupted. CONCLUSIONS: The 2 percent concentration of drug not only did not show potent anti-inflammatory effects, but also improved the process of healing by blocking the connexin 43 and inhibition of ATP release, while in the concentration of 5 and 10 percent, anti-inflammatory effects of the drug predominated and delayed the healing process.
Afficher plus [+] Moins [-]